Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $38,520,000 | reported | |
| FY 2024 | 2024-12-31 | $40,903,000 | reported | |
| FY 2023 | 2023-12-31 | $50,224,000 | reported | |
| FY 2022 | 2022-12-31 | $52,281,000 | reported | |
| FY 2021 | 2021-12-31 | $49,054,000 | reported | |
| FY 2020 | 2020-12-31 | $42,178,000 | reported | |
| FY 2019 | 2019-12-31 | $46,904,000 | reported | |
| FY 2018 | 2018-12-31 | $41,998,000 | reported | |
| FY 2017 | 2017-12-31 | $41,414,000 | reported | |
| FY 2016 | 2016-12-31 | $39,298,000 | reported | |
| FY 2015 | 2015-12-31 | $40,157,000 | reported | |
| FY 2014 | 2014-12-31 | $41,278,000 | reported |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
Twelve months to Jun 30, 2026 · derived
Utah Medical Products Inc is the 68th largest of the 147 covered companies the SEC files under this code, by revenue. SIC 3841
Latest filing Sep 29, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $3.98M | $8.36M | $12.34M | — | 3.19M sh | −2.9% | 86.2% |
| FY2024 | $4.26M | $19.97M | $24.23M |
| — |
| 3.28M sh |
| −8.6% |
| 165.9% |
| FY2023 | $4.28M | $0.00 | $4.28M | — | 3.59M sh | −1.1% | 19.8% |
| FY2022 | $3.16M | $2.50M | $5.66M | — | 3.63M sh | −0.7% | 27.8% |
| FY2021 | $11.47M | $0.00 | $11.47M | — | 3.65M sh | +0.3% | 55.5% |
No reported open-market purchases or sales in the last 12 months.